Moving towards an era of hybrid modelling: advantages and challenges of coupling mechanistic and data-driven models for upstream pharmaceutical bioprocesses
Open accessThe DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.
Abstract
Monoclonal antibodies (mAbs) are the highest-selling class of biopharmaceuticals due to their capabilities in treating severe illnesses. Thus, strategies to optimise their manufacture have been at the centre of recent academic and industrial research. Mechanistic and statistical modelling approaches are considered useful tools in that quest, not only because they can be employed for online process monitoring but also due to their abilities to offer useful insight into how the underlying micro and macro-scale phenomena of upstream bioprocesses impact the yield and quality of biopharmaceuticals. This manuscript provides an overview of the mechanistic and statistical models of upstream mAb bioprocesses that have been published over the past five years and discusses their advantages and drawbacks. We conclude with an outline of synergistic, hybrid modelling strategies, which are emerging as key tools in the era of Biopharma 4.0.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Biopharmaceutical benchmarks 2018
Walsh, G. (2018) · Nature Biotechnology · doi:10.1038/nbt.4305 · Cited by 978
Therapeutic glycoprotein production in mammalian cells
Lalonde, M.-E., & Durocher, Y. (2017) · Journal of Biotechnology · doi:10.1016/j.jbiotec.2017.04.028 · Cited by 296
Between the Poles of Data‐Driven and Mechanistic Modeling for Process Operation
Solle, D., Hitzmann, B., Herwig, C., Pereira Remelhe, M., Ulonska, S., Wuerth, L., Prata, A., & Steckenreiter, T. (2017) · Chemie Ingenieur Technik · doi:10.1002/cite.201600175 · Cited by 134
Model-assisted Design of Experiments as a concept for knowledge-based bioprocess development
Möller, J., Kuchemüller, K. B., Steinmetz, T., Koopmann, K. S., & Pörtner, R. (2019) · Bioprocess and Biosystems Engineering · doi:10.1007/s00449-019-02089-7 · Cited by 100
Model-based optimization of antibody galactosylation in CHO cell culture
Kotidis, P., Jedrzejewski, P., Sou, S. N., Sellick, C., Polizzi, K., del Val, I. J., & Kontoravdi, C. (2019) · Biotechnology and Bioengineering · doi:10.1002/bit.26960 · Cited by 90
Bhatia, H., Mehdizadeh, H., Drapeau, D., & Yoon, S. (2018) · Engineering in Life Sciences · doi:10.1002/elsc.201700084 · Cited by 87
On-line soft sensing in upstream bioprocessing
Randek, J., & Mandenius, C.-F. (2018) · Critical Reviews in Biotechnology · doi:10.1080/07388551.2017.1312271 · Cited by 86
Cited by
A review and perspective on hybrid modeling methodologies
Schweidtmann, A. M., Zhang, D., & von Stosch, M. (2024) · Digital Chemical Engineering · doi:10.1016/j.dche.2023.100136 · Cited by 178
Modern Sensor Tools and Techniques for Monitoring, Controlling, and Improving Cell Culture Processes
Reyes, S. J., Durocher, Y., Pham, P. L., & Henry, O. (2022) · Processes · doi:10.3390/pr10020189 · Cited by 130
Model-based intensification of CHO cell cultures: One-step strategy from fed-batch to perfusion
Richelle, A., Corbett, B., Agarwal, P., Vernersson, A., Trygg, J., & McCready, C. (2022) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2022.948905 · Cited by 22
Mishra, A., Aghaee, M., Tamer, I. M., & Budman, H. (2025) · Spectroscopy Journal · doi:10.3390/spectroscj3020012 · Cited by 19
“Thus, confining the solution space by satisfying a mechanistic model enhances the model’s predictive capabilities, while automated model generation reduces the expertise necessary for industrial deployment [61].”
Process modeling of recombinant adeno-associated virus production in HEK293 cells
Joiner, J., Huang, Z., McHugh, K., Stebbins, M., Aron, K., Borys, M., & Khetan, A. (2022) · Current Opinion in Chemical Engineering · doi:10.1016/j.coche.2022.100823 · Cited by 17
Metadata
- Authors
- Tsopanoglou, A., & Jiménez del Val, I.
- Venue
- Current Opinion in Chemical Engineering
- Publisher
- Elsevier BV
- Published
- 2021-06
- Volume
- 32
- Pages
- 100691
- ISSN
- 2211-3398 (ISSN-L)
- OpenAlex
- W3172711957
- Cited by
- 107
- References
- 7
- FWCI
- 1.51
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Moving towards an era of hybrid modelling: advantages and challenges of coupling mechanistic and data-driven models for upstream pharmaceutical bioprocesses. https://app.cochat.ai/papers/10.1016/j.coche.2021.100691
- The paper
- Tsopanoglou, A., & Jiménez del Val, I. (2021). Moving towards an era of hybrid modelling: advantages and challenges of coupling mechanistic and data-driven models for upstream pharmaceutical bioprocesses. Current Opinion in Chemical Engineering. https://doi.org/10.1016/j.coche.2021.100691
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.